Iraq and Afghanistan Veterans Report Symptoms Consistent with Chronic Multisymptom Illness One Year After Deployment by McAndrew, Lisa M. et al.
University at Albany, State University of New York
Scholars Archive
Educational & Counseling Psychology Faculty
Scholarship Educational & Counseling Psychology
2016
Iraq and Afghanistan Veterans Report Symptoms
Consistent with Chronic Multisymptom Illness
One Year After Deployment
Lisa M. McAndrew
University at Albany, State University of New York, lmcandrew@albany.edu
Drew A. Helmer
New Jersey Medical School, Rutgers University
L. Alison Phillips
Iowa State University
Helena K. Chandler
New Jersey Health Care System
Kathleen Ray
New Jersey Health Care System
See next page for additional authors
Follow this and additional works at: http://scholarsarchive.library.albany.edu/edpsych_fac_scholar
Part of the Educational Psychology Commons
This Article is brought to you for free and open access by the Educational & Counseling Psychology at Scholars Archive. It has been accepted for
inclusion in Educational & Counseling Psychology Faculty Scholarship by an authorized administrator of Scholars Archive. For more information,
please contact scholarsarchive@albany.edu.
Recommended Citation
McAndrew, Lisa M.; Helmer, Drew A.; Phillips, L. Alison; Chandler, Helena K.; Ray, Kathleen; and Quigley, Karen S., "Iraq and
Afghanistan Veterans Report Symptoms Consistent with Chronic Multisymptom Illness One Year After Deployment" (2016).
Educational & Counseling Psychology Faculty Scholarship. 8.
http://scholarsarchive.library.albany.edu/edpsych_fac_scholar/8
Authors
Lisa M. McAndrew, Drew A. Helmer, L. Alison Phillips, Helena K. Chandler, Kathleen Ray, and Karen S.
Quigley
This article is available at Scholars Archive: http://scholarsarchive.library.albany.edu/edpsych_fac_scholar/8
59
JRRD Volume 53, Number 1, 2016Pages 59–70
Iraq and Afghanistan Veterans report symptoms consistent with chronic 
multisymptom illness one year after deployment
Lisa M. McAndrew, PhD;1–3* Drew A. Helmer, MD, MS;1,3 L. Alison Phillips, PhD;4 Helena K. Chandler, PhD;1 
Kathleen Ray, PhD;1 Karen S. Quigley, PhD5
1War Related Illness and Injury Study Center, Department of Veterans Affairs (VA) New Jersey Health Care System, 
East Orange, NJ; 2Department of Educational and Counseling Psychology, University at Albany, Albany, NY; 3New 
Jersey Medical School, Rutgers University, Newark, NJ; 4Department of Psychology, Iowa State University, Ames, IA; 
5Edith Nourse Rogers Memorial VA Hospital, Bedford, MA; and Department of Psychology, Northeastern University, 
Boston, MA
Abstract—Many Veterans returning from service in Operation 
Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) expe-
rience chronic pain. What is not known is whether for some 
OIF/OEF Veterans this pain is part of a larger condition of dif-
fuse multisystem symptoms consistent with chronic multi-
symptom illness (CMI). We use data from a prospective 
longitudinal study of OIF/OEF Veterans to determine the fre-
quency of CMI. We found that 1 yr after deployment, 49.5% of 
OIF/OEF Veterans met criteria for mild to moderate CMI and 
10.8% met criteria for severe CMI. Over 90% of Veterans with 
chronic pain met criteria for CMI. CMI was not completely 
accounted for either by posttraumatic stress disorder or by pre-
deployment levels of physical symptoms. Veterans with symp-
toms consistent with CMI reported significantly worse 
physical health function than Veterans who did not report 
symptoms consistent with CMI. This study suggests that the 
presence of CMI should be considered in the evaluation of 
OIF/OEF Veterans. Further, it suggests that the pain manage-
ment for these Veterans may need to be tailored to take CMI 
into consideration.
Key words: chronic multisymptom illness, chronic pain, com-
bat deployment, mental health function, Operation Iraqi Free-
dom/Operation Enduring Freedom, pain management, Persian 
Gulf war, physical health function, PTSD, Veterans.
INTRODUCTION
Chronic pain is a significant and complex problem 
for Veterans who deployed to Iraq (Operation Iraqi Free-
dom [OIF]) and Afghanistan (Operation Enduring Free-
dom [OEF]). Forty-three percent of OIF/OEF Veterans 
seeking treatment at a Department of Veterans Affairs 
(VA) hospital reported pain, with 63 percent of those Vet-
erans reporting clinically significant pain [1]. Further, 
Abbreviations: ANCOVA = analysis of covariance, CDC = 
Centers for Disease Control and Prevention, CMI = chronic 
multisymptom illness, HEROES = Healthy Resilience after 
Operational and Environmental Stressors, MCS = mental health 
composite score, mTBI = mild traumatic brain injury, OEF =
Operation Enduring Freedom, OIF = Operation Iraqi Freedom, 
PCS = physical health composite score, PHQ-15 = Patient 
Health Questionnaire-15, PTSD = posttraumatic stress disor-
der, VA = Department of Veterans Affairs, VR-36 = Veterans 
RAND 36-Item Health Survey.
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OIF/OEF Veterans with chronic pain have worse physical 
health function than OIF/OEF Veterans without chronic 
pain [2]. Finally, OIF/OEF Veterans with chronic pain are 
more likely to present with another postdeployment 
health condition (i.e., posttraumatic stress disorder 
[PTSD], mild traumatic brain injury [mTBI], and/or 
polysubstance abuse) [3] than to present with only 
chronic pain. What is not known is how often chronic 
musculoskeletal pain presents with other chronic and 
comorbid symptoms, such as chronic fatigue, gastrointes-
tinal distress, or cognitive problems such as difficulty 
finding words. It is possible that for some OIF/OEF Vet-
erans, chronic pain may be only one symptom of a larger 
multisymptom syndrome. Walker et al. suggested that the 
most common health concern of OIF/OEF Veterans are 
diffuse, widespread, and overlapping physical, cognitive, 
and emotional symptoms [4].
There is good reason to suspect that some OIF/OEF 
Veterans with chronic pain are also experiencing other 
chronic symptoms. Multisystem diffuse symptoms have 
been common in Veterans after every modern war [5–6]. 
This was particularly clear after the Persian Gulf war 
(Operation Desert Shield/Operation Desert Storm), when 
an estimated 30 percent of Veterans experienced multiple 
chronic symptoms [7–10]. Termed chronic multisymp-
tom illness (CMI) (or Gulf War Illness), the Centers for 
Disease Control and Prevention (CDC) defines CMI
as having one or more chronic symptoms (6 mo dura-
tion) from two or more symptom categories: (1) fatigue,
(2) mood and cognition (e.g., concentration problems, 
depression), or (3) musculoskeletal (e.g., joint pain) [11]. 
Evidence has found that CMI is distinct from PTSD or 
depression [12]. CMI causes disability that is as severe as 
found in other chronic illnesses and continues to affect 
Persian Gulf war Veterans many years after their deploy-
ment [7,13].
There is preliminary evidence to suggest that OIF/
OEF Veterans may also be experiencing increases in 
widespread symptoms. Three cross-sectional studies 
found heightened physical symptom severity as mea-
sured with the Patient Health Questionnaire-15 (PHQ-
15). Iverson et al. reported that 41 percent of women and 
31 percent of men deployed to OIF/OEF reported 
medium or higher levels of physical symptom severity 
[14]. McAndrew et al. reported on the relationship 
between physical symptoms and environmental exposure 
concerns among OIF/OEF Veterans seeking care at a VA 
tertiary clinic [15]. They found, on average, medium levels 
of physical symptom severity, and symptom severity was 
positively associated with environmental exposure con-
cerns [15]. Similarly, Hoge et al. found, on average, 
medium levels of physical symptom severity among OIF/
OEF Veterans and higher symptom severity among OIF/
OEF Veterans with PTSD [16]. Medium levels of symp-
toms are associated with a greater number of physician 
visits and more disability days [17].
Especially compelling evidence comes from the Mil-
lennium Cohort Study. The Millennium Cohort Study is a 
prospective longitudinal study of 73,078 OIF/OEF mili-
tary personnel [18], which used a close approximation of 
the CDC definition of CMI with some modifications 
(e.g., two instead of three pain symptoms, “unusual 
fatigue” instead of general fatigue). Comparing military 
personnel who deployed with those who did not deploy, 
this study found that combat deployment resulted in a 1.7 
times increase in odds of meeting CMI criteria. Further, 
an estimated 26.5 percent of OIF/OEF Veterans who 
deployed met criteria for CMI after deployment. These 
data suggest that CMI is a problem among OIF/OEF Vet-
erans, a view also suggested by the Institute of Medicine 
[19]. These existing studies are limited by not having 
used the specific CDC definition; thus, we do not yet 
know whether OIF/OEF Veterans meet that definition of 
CMI. Further, no existing study has used a pre-post 
deployment longitudinal design that provides the ability 
to assess whether symptoms increase after combat 
deployment or whether OIF/OEF soldiers could have 
been experiencing heightened symptoms prior to combat 
deployment.
To optimally address pain among OIF/OEF Veterans, 
it is critical that we understand whether CMI is a problem 
among these Veterans, and if so, its relationship to 
chronic pain. The presence of chronic pain in the context 
of CMI likely necessitates modification of pain manage-
ment treatments. Focusing exclusively on chronic pain 
without taking into account the patients’ other symptoms 
may lead to poor adherence to treatment recommenda-
tions and low satisfaction with care. Similarly, treatments 
for CMI need to be tailored when the predominant symp-
tom is pain as compared with when the predominant 
symptoms are fatigue or gastrointestinal distress.
The goal of the current study was to report the fre-
quency of CMI in soldiers returning from war using data 
from a longitudinal, prospective study, the Healthy Resil-
ience after Operational and Environmental Stressors 
(HEROES) Project. The HEROES Project improves upon 
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limitations of past studies by using the CDC definition of 
CMI and using a pre-post deployment longitudinal 
design. The aims of the current study were to—
1. Estimate the frequency of OIF/OEF Veterans who report 
symptoms consistent with CMI at 1 yr postdeployment.
2. Examine the relationship between CMI at 1 yr postde-
ployment and chronic pain symptoms at 1 yr postde-
ployment, PTSD symptoms at 1 yr postdeployment, 
and physical symptom severity at predeployment.
3. Determine the relationship of CMI assessed at 1 yr 
postdeployment to physical and mental health function 
at 1 yr postdeployment, controlling for physical symp-
tom severity and health function at predeployment and 
PTSD symptoms at 1 yr postdeployment.
METHODS
The HEROES Project is a prospective longitudinal 
observational cohort design with measures collected at 
four time points: predeployment, immediately postde-
ployment, 3 mo postdeployment, and 1 yr postdeploy-
ment (for description see McAndrew et al., Yan et al., and 
Quigley et al. [20–22]).
Participants
Participants were Army National Guard and Army 
Reserve enlisted soldiers (including noncommissioned 
officers) deploying to either OIF or OEF who partici-
pated in the HEROES Project [20–22]. Exclusion criteria 
were current self-reported depression, medications with 
cardiovascular and/or autonomic effects (e.g., beta block-
ers or other antihypertensive medication), history of 
schizophrenia or bipolar disorder or current cancer, high 
blood pressure, or pregnancy. The larger study included a 
physiological assessment (not reported here) that necessi-
tated excluding patients on medications with cardiovas-
cular and/or autonomic effects and those with high blood 
pressure.
At the 1 yr postdeployment assessment, 319 soldiers 
completed the questionnaire on CMI. This was from an 
initial study sample of 795 soldiers (at predeployment). 
Out of the initial sample, 32 did not mobilize, were offi-
cers, or were severely injured or killed in action. At 1 yr 
postdeployment, 118 participants declined to participate 
(14.8%). The remainder of the participants whose data 
were missing at 1 yr postdeployment were lost to follow-
up. Most of these were lost to follow-up because we did 
not receive information on when they returned from 
deployment (n = 289); for the others we do not have 
information on the reasons they were lost to follow-up
(n = 37). Physical symptom severity at baseline was not 
related to the likelihood of being lost to follow-up at 1 yr 
postdeployment (X2 = 0.80, p = 0.85).
Procedure
Study personnel approached soldiers who had just 
finished their medical processing or were waiting to com-
plete their medical processing. We emphasized the volun-
tary nature of their participation and that research staff 
were civilian VA personnel. We examined differences 
between those who volunteered and those who declined 
to participate. There was no significant difference in the 
proportion of males and females in the participant and 
nonparticipant groups (X2 = 2.30, p = 0.13). However, 
using a dichotomized variable for general health (excel-
lent/very good vs good/fair/poor), there was a small but 
statistically significant difference between the participant 
sample and the nonparticipant sample. There were fewer 
individuals reporting excellent/very good health in the 
participant sample (72.1% of participant sample vs 
78.8% of nonresponse sample; X2 = 8.25, p < 0.01). We 
choose to ask about general health because it was only 
one item and has previously been shown to prospectively 
predict health.
Following recruitment, soldiers were given informa-
tion about the study and screened for eligibility, and those 
who were eligible and interested gave informed consent. 
Soldiers completed predeployment self-report question-
naires and physiological measures (not included here) 
while at the Army installation. Immediately postdeploy-
ment, soldiers again completed self-report questionnaires 
at the Army installation. Soldiers who did not return to 
their installation were sent the immediate postdeploy-
ment questionnaires via mail. Data at 3 mo and 1 yr post-
deployment were collected through mailed questionnaires.
This report focuses on self-report of CMI measured at 1 yr
postdeployment controlling for predeployment factors. 
The protocol was approved by Institutional Review 
Boards of the VA (VA New Jersey Healthcare System and 
the G.V. [Sonny] Montgomery VA Medical Center) and by 
the Walter Reed Department of Clinical Investigation.
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Measures
Chronic Multisymptom Illness 
CMI was assessed at 1 yr after deployment using the 
CDC definition. The Institute of Medicine recently 
released a report that reviewed the evidence for a case 
definition of CMI. They recommended using either the 
CDC definition or the Kansas definition [23–24] because 
both encompassed most of the symptoms of CMI. We 
chose to use the CDC definition because it provided a 
broader definition of CMI and can more easily be 
assessed through self-report because the Kansas defini-
tion requires assessment of possible medical exclusions. 
To meet the CDC criteria for CMI, participants are asked 
about the severity (mild, moderate, or severe) and dura-
tion (6 mo duration) of 10 common symptoms. CMI is 
defined as having one or more chronic symptoms (6 mo 
duration) from two or more symptom categories. The 
three symptom categories are (1) fatigue, (2) mood and 
cognition (symptoms of feeling depressed, difficulty 
remembering or concentration, feeling moody, feeling 
anxious, trouble finding words, or difficulty sleeping), 
and (3) musculoskeletal (symptoms of joint pain, joint 
stiffness, or muscle pain). We classified participants as 
having severe CMI if at least one symptom in two or 
more categories was rated as severe. We also asked about 
25 additional symptoms that do not contribute to the def-
inition of CMI. The prevalence of both CMI and these 
other symptoms is presented in Table 1.
Patient Health Questionnaire-15
Physical symptom severity was assessed at prede-
ployment with the PHQ-15 [17]. Participants were asked 
to indicate, “During the past 7 days, how much have you 
been bothered by any of the following problems.” Each 
item is scored as 0 (not bothered at all), 1 (bothered a lit-
tle), or 2 (bothered a lot). Generally, cut offs of 0–4 (min-
imal), 5 (low), 10 (medium), and 15 (high) are used to 
create physical symptoms severity categories [17]. Items 
include stomach pain; back pain; pain in arms, legs, or 
joints; menstrual cramps or other problems with periods; 
headaches; chest pain; dizziness; fainting spells; feeling 
the heart pound or race; shortness of breath; pain or prob-
lems during sexual intercourse; constipation; loose bow-
els or diarrhea; nausea; gas or indigestion; feeling tired or 
having low energy; and trouble sleeping.
Health Function—Veterans RAND 36-Item Health Survey 
The Veterans RAND 36-Item Health Survey (VR-36) 
is a measure of mental and physical health function [25–
27] and was assessed at predeployment and 1 yr postde-
ployment. The VR-36 was developed from the 36-Item 
Short Form Health Survey. The VR-36 provides two 
composite scores, physical function (physical health 
composite score [PCS]) and mental function (mental 
health composite score [MCS]). These composite scores 
are composed of eight subscale scores: physical function-
ing, bodily pain, role limitations due to physical health 
problems, role limitations due to personal or emotional 
problems, emotional well-being, social functioning, 
energy/fatigue, and general health perceptions. Compos-
ite and subscale scores are normed to a mean of 50 and a 
standard deviation of 10.
Posttraumatic Stress Disorder Checklist for Diagnostic 
and Statistical Manual of Mental Disorders-Fourth 
Edition
PTSD symptoms were assessed at 1 yr postdeploy-
ment with the Posttraumatic Stress Disorder Checklist-
Civilian, which assesses for 17 symptoms of PTSD [28–
29]. Participants were asked to indicate “in the past 
month, how much were you bothered by” each of 17 
symptoms. Items are scored on a scale of 1 to 5. A score 
of 50 or greater is commonly used to denote significant 
PTSD symptoms [30].
Analysis
We first provide the frequency of CMI and specific 
physical symptoms at 1 yr postdeployment. A Pearson 
correlation was used to examine the relationship between 
CMI and age. Chi-square analyses were used to examine 
the relationship of CMI to sex and whether or not a par-
ticipant had previously deployed, which prior research 
found to be related to increases in physical symptoms [31].
We next report the percentage of Veterans with mus-
culoskeletal chronic pain who met criteria for CMI. To 
measure chronic pain, we used the musculoskeletal cate-
gory of the CMI measure (≥1 symptoms of joint pain, 
joint stiffness, and muscle pain). We considered not 
including joint stiffness, but only eight Veterans reported 
joint stiffness without joint or muscle pain. Chi-square 
analyses were conducted to understand the relationship of 
chronic pain to CMI. Chi-square analyses were also used to 
examine the relationship of CMI to PTSD symptoms at 1 yr 
postdeployment and CMI to predeployment physical 
symptoms.
Symptom Mild Moderate Severe Total
Sinus Congestion 43 (13.5) 38 (12.0) 15 (4.7) 96 (30.0)
Headache 46 (14.4) 35 (11.0) 34 (10.7) 115 (36.1)
Fatigue 55 (17.2) 50 (15.7) 21 (6.6) 126 (39.5)
Joint Pain 51 (16.0) 69 (22) 28 (8.8) 148 (46.0)
Difficulty Remembering or Concentrating 60 (18.8) 42 (13.2) 25 (7.8) 127 (39.8)
Joint Stiffness 40 (12.5) 50 (15.7) 18 (5.6) 108 (33.9)
Difficulty Sleeping 44 (13.8) 68 (21.3) 52 (16.3) 164 (51.4)
Gas, Bloating, Cramps, or Abdominal Pain 20 (6.3) 25 (7.8) 10 (3.1) 55 (17.2)
Trouble Finding Words 34 (10.7) 24 (7.5) 15 (4.7) 73 (22.9)
Moody or Irritable 65 (20.4) 61 (19.1) 36 (11.3) 162 (50.8)
Rash or Sores 11 (3.4) 11 (3.4) 5 (1.6) 27 (8.5)
Numbness or Tingling 31 (9.7) 24 (7.5) 6 (1.9) 61 (19.1)
Muscle Pain 31 (9.7) 33 (10.3) 7 (2.2) 71 (22.2)
Hay Fever or Allergies 27 (8.5) 21 (6.6) 15 (4.7) 63 (19.7)
Feeling Depressed 48 (15.0) 27 (8.5) 16 (5.0) 91 (28.5)
Diarrhea (>3 loose stool samples per 24 h) 15 (4.7) 14 (4.4) 6 (1.9) 35 (11.0)
Sore Throat 9 (2.8) 3 (0.9) 0 (0) 12 (3.8)
Cough 25 (7.8) 8 (2.5) 4 (1.3) 37 (11.6)
Feeling Anxious 44 (13.8) 43 (13.5) 19 (6.0) 106 (33.2)
Unintentional Weight Gain 10 lb 24 (7.5) 36 (11.3) 15 (4.7) 75 (23.5)
Shortness of Breath 22 (6.9) 17 (5.3) 6 (1.9) 45 (14.1)
Chest Pain 15 (4.7) 9 (2.8) 3 (0.9) 27 (8.5)
Decreased Interest in Sex 21 (6.6) 15 (4.7) 14 (4.3) 50 (15.7)
Dizziness or Trouble Maintaining Balance 21 (6.6) 9 (2.8) 4 (1.3) 34 (10.7)
Night Sweats that Soak Bed Sheets 13 (4.1) 14 (4.4) 10 (3.1) 37 (11.6)
Fatigue Lasting 24 h After Exertion 18 (5.6) 11 (3.4) 9 (2.8) 38 (11.9)
Nasal Sores 4 (1.3) 5 (1.6) 0 (0) 9 (2.8)
Swollen Lymph Nodes 4 (1.3) 2 (0.6) 3 (0.9) 9 (2.8)
Milk Intolerance 7 (2.2) 8 (2.5) 7 (2.2) 22 (6.9)
Episodes of Disorientation 14 (4.4) 5 (1.6) 2 (0.6) 21 (6.6)
Nausea and Vomiting 8 (2.5) 5 (1.6) 3 (0.9) 16 (5.0)
Wheezing 6 (1.9) 9 (2.8) 1 (0.3) 16 (5.0)
Chemical Sensitivity 5 (1.6) 6 (1.9) 3 (0.9) 14 (4.4)
Fever 5 (1.6) 3 (0.9) 1 (0.3) 9 (2.8)
Unintentional Weight Loss >10 lb 5 (1.6) 1 (0.3) 3 (0.9) 9 (2.8)
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Finally, we were interested in the relationship of CMI 
to health function. We first graphically depicted health 
function scores for each subscale of the VR-36 at three 
levels of CMI (no CMI, mild to moderate CMI, and 
severe CMI). We then used two analyses of covariance 
(ANCOVAs) to examine the relationship of CMI (no 
CMI, mild to moderate CMI, and severe CMI) to a com-
posite score of mental health function (MCS) and a com-
posite score of physical health function (PCS). Generally, 
a 2 to 3 point difference on these scores is considered 
clinically significant. In both models, we respectively 
controlled for the MCS or PCS at predeployment and the 
physical symptom severity from the PHQ-15 at prede-
ployment. Examining postdeployment health function 
while controlling for predeployment levels of health 
function allows us to understand the relationship of CMI 
to postdeployment health function independent of prede-
ployment levels. Similarly, controlling for predeploy-
ment physical symptoms allows us to understand the 
effect of symptoms that emerge after deployment (con-
trolling for pre-existing symptom severity) on health 
function. We also controlled for PTSD symptoms at 1 yr 
Table 1.
Operation Iraqi Freedom/Operation Enduring Freedom soldiers reporting symptoms with duration of greater than 6 mo at 1 yr after return from 
deployment, n (%). Bolded items are symptoms of chronic multisymptom illness from Centers for Disease Control and Prevention definition.
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postdeployment, age, and sex because these also are 
related to health function.
RESULTS
Prevalence of Chronic Multisymptom Illness
At 1 yr after return from deployment, physical symp-
toms were assessed using the CDC measure of CMI; 
46.7 percent reported physical symptoms consistent with 
CMI, and 10.8 percent reported symptoms consistent 
with severe CMI. Reporting physical symptoms consis-
tent with CMI at 1 yr after return from deployment was 
not related to sex (X2 = 1.49, p = 0.47) or to having 
deployed previously (X2 = 2.89, p = 0.24). Meeting CMI 
criteria was related to greater age (r = 0.19, p < 0.01).
Physical Symptoms in Those with Chronic 
Multisymptom Illness
The prevalence of the 10 chronic (duration 6 mo) 
physical symptoms that define CMI at 1 yr postdeploy-
ment are listed in Table 1 (in bold). The severity and 
duration of an additional 25 physical symptoms are listed 
in Table 1. The most common symptoms were difficulty 
sleeping (51.4%), being moody or irritable (50.8%), joint 
pain (46.0%), fatigue (39.5%), difficulty remembering or 
concentrating (39.8%), headaches (36.1%), and sinus 
congestion (30.0%). 
Relationship of Chronic Multisymptom Illness 
to Pain Symptoms
We compared the number of Veterans who reported 
chronic musculoskeletal pain symptoms (defined as 
reporting either joint pain, joint stiffness, or muscle pain 
lasting 6 mo or longer) with the number of Veterans who 
reported symptoms consistent with CMI. We found a 
total of 166 (52%) Veterans reported chronic musculo-
skeletal pain, and 150 of these Veterans or 90 percent of 
those with musculoskeletal pain also met criteria for 
CMI. Thus, the vast majority of those reporting chronic 
musculoskeletal pain met criteria for CMI. Further, 
82 percent of those who met criteria for CMI reported 
chronic pain (X2 = 291.83, p < 0.01).
Relationship of Chronic Multisymptom Illness to 
Posttraumatic Stress Disorder
At 1 yr postdeployment, almost all Veterans who 
reported symptoms consistent with PTSD also reported 
symptoms consistent with CMI or severe CMI (X2 = 
47.27, p < 0.01). Only seven (2.2%) Veterans reported 
symptoms consistent with PTSD but did not meet criteria 
for CMI. However, 140 (43.9%) Veterans met criteria for 
CMI (5% severe CMI) but not did not report symptoms 
consistent with PTSD (Figure 1).
Figure 1.
Frequency of chronic multisymptom illness (CMI) and posttrau-
matic stress disorder (PTSD) among Operation Iraqi Freedom/
Operation Enduring Freedom soldiers 1 yr after deployment.
Relationship of Chronic Multisymptom Illness to 
Predeployment Symptoms
Of the Veterans who provided responses at 1 yr post-
deployment, at predeployment 162 (50.9%) reported 
minimal physical symptom severity, 112 (35%) reported 
low physical symptom severity, 38 (11%) reported medium 
physical symptom severity, and 6 (1%) reported high physi-
cal symptom severity.
Chi-square analyses showed that soldiers who 
reported greater symptom severity at predeployment 
were more likely to report physical symptoms consistent 
with CMI 1 yr postdeployment (X2 = 17.84, p = 0.01; 
Table 2). All of the soldiers who reported high symptom 
severity at baseline also met criteria for CMI at 1 yr post-
deployment. Importantly, 150 (47%) soldiers who reported
minimal symptom severity (i.e., the lowest category) at 
baseline also reported physical symptoms consistent with 
CMI at 1 yr postdeployment.
Baseline Physical 
Symptom Severity
No
CMI
Mild to 
Moderate 
CMI
Severe 
CMI
Minimal 85 (52.5) 64 (39.5) 13 (8.0)
Low 40 (35.4) 59 (52.2) 13 (12.4)
Medium 11 (28.9) 22 (57.9) 5 (13.2)
High 0 (0) 4 (66.7) 2 (33.3)
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Relationship of Chronic Multisymptom Illness to 
Physical and Mental Health Function
Figure 2 
Figure 2.
Physical and mental health function subscales of Veterans 
RAND 36-Item Health Survey (VR-36) at 1 yr postdeployment 
for soldiers with no chronic multisymptom illness (CMI), mild to 
moderate CMI, and severe CMI. Higher scores (y-axis) indicate 
better functioning.
depicts mental and physical health function 
at 1 yr postdeployment for Veterans who did not screen 
positive for CMI, Veterans who screened positive for 
mild to moderate CMI, and Veterans who screened posi-
tive for severe CMI. For reference, a 2 to 3 point difference 
on one of the subscales of the VR-36 is generally consid-
ered clinically significant. For each subscale, Veterans 
who screened positive for severe CMI reported function-
ing 10 points or more lower than that in soldiers who did 
not screen positive for CMI.
Two ANCOVAs were used to determine the relation-
ship of CMI (no CMI, mild to moderate CMI, and severe 
CMI) to composite scores of mental (Table 3) and physi-
cal health function (Table 4). CMI was strongly related 
to physical health function 1 yr after deployment after 
controlling for predeployment levels of physical health 
function and physical symptoms, and for PTSD symp-
toms at 1 yr after deployment. CMI and mental health 
function were not significantly associated after control-
ling for predeployment levels of mental health function 
and physical symptoms, and PTSD symptoms at 1 yr 
postdeployment.
DISCUSSION
Chronic pain is a significant problem for OIF/OEF 
Veterans. For some OIF/OEF Veterans, this chronic pain 
may be part of a larger multisystem condition, termed 
CMI. Using a prospective longitudinal study of OIF/OEF 
soldiers, we found that 49.5 percent of OIF/OEF Veterans 
met criteria for mild to moderate CMI at 1 yr after 
deployment, and 10.8 percent met criteria for severe 
CMI. Almost all Veterans with chronic musculoskeletal 
pain also met criteria for CMI (90%). In this study, nei-
ther mild to moderate nor severe CMI were completely 
accounted for by PTSD or by predeployment levels of 
physical symptom severity. Further, Veterans who met 
criteria for either mild to moderate or severe CMI also 
reported clinically and statistically significantly worse 
physical health function than soldiers without CMI, even 
after controlling for predeployment physical health func-
tion and physical symptoms and PTSD symptoms at 1 yr 
postdeployment. To put this in perspective, on average, 
soldiers with severe CMI had physical health function 
almost as low as civilians with chronic illness [32].
Our results suggest that for some, if not many, OIF/
OEF Veterans with chronic musculoskeletal pain, their 
chronic pain may be part of a larger CMI. This has impli-
cations for pain management or treatment. Providers 
should consider asking about and addressing the other 
chronic symptoms of OIF/OEF Veterans. Prior research has
found that when providers’ and patients’ views on illnesses 
are nonconcordant, the patient is less adherent to treat-
ment recommendations and less satisfied with the care 
[33]. For Veterans with chronic pain, treatments focused 
Table 2.
Predeployment physical symptom severity and chronic multisymptom 
illness (CMI) status 1 yr after deployment, n (%).
Characteristic Mean Square F p-Value
Sex 0.44 0.01 0.93
Age 431.50 7.55 0.01
Predeployment Physical Functioning 1,113.12 19.47 0.00
Predeployment Physical Symptoms 0.57 0.01 0.92
PTSD symptoms 1 yr After Deployment 654.40 11.45 <0.001
CMI 1 yr After Deployment 587.65 10.28 <0.001
Characteristic Mean Square F p-Value
Sex 170.41 2.14 0.14
Age 114.73 1.44 0.23
Predeployment Mental Health Functioning 1,392.74 17.50 0.00
Predeployment Physical Symptoms 129.89 1.63 0.20
PTSD Symptoms 1 yr After Deployment 13,464.31 169.16 <0.001
CMI 1 yr After Deployment 155.75 1.96 0.14
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on chronic pain that ignore the Veterans’ fatigue or cog-
nitive dysfunction may lead to poorer adherence and sat-
isfaction. Management for Veterans with CMI may 
require going beyond traditional pain management 
approaches. For example, cognitive behavioral therapy is 
a recommended treatment for chronic pain. However, 
there likely needs to be greater tailoring of cognitive 
behavioral therapy to the specific needs of Veterans with 
CMI [34]. This may include treatment to improve sleep, 
scheduling of pleasant activities around episodes of 
fatigue, and cognitive remediation treatment.
After the Persian Gulf war, there was a prominent 
focus on CMI (called Gulf War Illness), the associated 
poor functioning [7], and the possible overlap of this con-
dition with PTSD symptoms [16]. In contrast, the clinical 
focus for OIF/OEF Veterans has been on multiple diag-
noses, each of which can be associated with significant 
physical symptoms, including chronic pain, PTSD, 
mTBI, depression, and polysubstance abuse [16,35–37]. 
Our study was limited in that we only assessed PTSD and 
pain symptoms and did not have measures of these other 
common postdeployment health conditions. However, it 
seems unlikely that unmeasured depression, mTBI, and 
substance abuse can fully account for the physical symp-
toms observed here. First, depression and substance 
abuse frequently co-occur with CMI but in prior studies 
have not been demonstrated to account for the symptoms 
of CMI (for a review see Burton [38]). Second, another 
possible candidate for the cause of CMI symptoms, 
mTBI, also appears unlikely to fully explain the extent of 
CMI. mTBI is thought to affect approximately 15 percent 
of OIF/OEF Veterans and commonly co-occurs with 
PTSD, yet we found that 43 percent of OIF/OEF Veter-
ans met criteria for CMI and did not meet criteria for 
PTSD. Thus, even if mTBI had no overlap with PTSD, 
there would still be an estimated 28 percent of our sam-
ple that met criteria for CMI but not for either PTSD or 
mTBI (i.e., 43% minus 15%). Future studies should mea-
sure the full range of possible comorbidities to better 
understand the relationship of CMI to each of these other 
postdeployment conditions.
There are several limitations of this study. Although 
the CDC definition for CMI is recommended by the Insti-
tute of Medicine, it is not without limitations. Most criti-
cally, there are no exclusion criteria for the CDC 
definition, and thus conditions such as HIV, multiple 
sclerosis, and rheumatoid arthritis may explain these 
symptoms for some of our participants. The relatively 
short time frame between deployment and demonstration 
of CMI in this sample, however, suggests that the overlap 
with chronic conditions like these should not yet be very 
high. Second, this definition was developed based on 
Table 3.
Analysis of covariance predicting physical health function 1 yr after deployment (adjusted R2 = 0.25).
CMI = chronic multisymptom illness, PTSD = posttraumatic stress disorder.
Table 4.
Analysis of covariance predicting mental health function 1 yr after deployment (adjusted R2 = 0.48).
CMI = chronic multisymptom illness, PTSD = posttraumatic stress disorder.
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symptom presentations in Persian Gulf war Veterans. The 
symptoms we found to be most common were not neces-
sarily those most commonly reported after the Persian 
Gulf war, suggesting that there may be a unique case def-
inition of CMI for OIF/OEF Veterans that takes into 
account deployment-related factors that differ for these 
deployments. Other limitations include that we did not 
have a complete assessment of CMI symptoms prede-
ployment, and thus had to rely on the PHQ-15–based 
measure of physical symptom severity at predeployment. 
We also did not have a validated measure of chronic mus-
culoskeletal pain. Finally, by using a self-report measure 
of CMI we are capturing the number of soldiers in our 
sample who have symptoms consistent with CMI. An 
interview with a provider is necessary to determine the 
best diagnosis.
CONCLUSIONS
To our knowledge, this is one of the first studies of 
CMI in OIF/OEF soldiers. Our data suggest that many 
OIF/OEF Veterans are experiencing multiple chronic 
symptoms that meet criteria for CMI. Further, meeting 
CMI criteria is associated with lower physical health 
function to an extent that is likely clinically significant. 
Finally, the prevalence of CMI in this sample is not fully 
accounted for by either predeployment physical symp-
toms or PTSD. Because we did not use a diagnostic inter-
view with a clinician, we do not know the best diagnosis 
for participants in this sample. However, our results sug-
gest that clinicians should consider CMI when assessing 
OIF/OEF Veterans with postdeployment health concerns. 
This includes considering broader treatment strategies 
that encompass both pain management as well as atten-
tion to other bothersome symptoms such as fatigue, trou-
ble sleeping, or cognitive symptoms.
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